Name: Bioinformatics of non Small Cell Lung Cancer and the ras Proto-Oncogene (Springerbriefs in Applied Sciences and Technology) (en Inglés)
Price: 97880.00 CLP
Availability: InStock
Author: Amita Kashyap; D. Bujamma; Naresh Babu M.
ISBN: 9789814585071

portada Bioinformatics of non Small Cell Lung Cancer and the ras Proto-Oncogene (Springerbriefs in Applied Sciences and Technology) (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Amita Kashyap; D. Bujamma; Naresh Babu M.

Año

2014

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

ISBN13

9789814585071

N° edición

2015

Categorías

Inteligencia artificial

Bioinformatics of non Small Cell Lung Cancer and the ras Proto-Oncogene (Springerbriefs in Applied Sciences and Technology) (en Inglés)

Amita Kashyap; D. Bujamma; Naresh Babu M. (Autor) · Springer · Tapa Blanda

Libro Nuevo

$ 97.880

$ 135.950

Ahorras: $ 38.070

28% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 18 de Julio y el Jueves 25 de Julio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Bioinformatics of non Small Cell Lung Cancer and the ras Proto-Oncogene (Springerbriefs in Applied Sciences and Technology) (en Inglés)"

Cancer is initiated by activation of oncogenes or inactivation of tumor suppressor genes. Mutations in the K-ras proto-oncogene are responsible for 10-30% of adenocarcinomas. Clinical Findings point to a wide variety of other cancers contributing to lung cancer incidence. Such a scenario makes identification of lung cancer difficult and thus identifying its mechanisms can contribute to the society. Identifying unique conserved patterns common to contributing proto-oncogenes may further be a boon to Pharmacogenomics and pharmacoinformatics. This calls for ab initio/de novo drug discovery that in turn will require a comprehensive in silico approach of Sequence, Domain, Phylogenetic and Structural analysis of the receptors, ligand screening and optimization and detailed Docking studies.This brief involves extensive role of the RAS subfamily that includes a set of proteins, which cause an over expression of cancer-causing genes like M-ras and initiate tumour formation in lungs. SNP Studies and Structure based drug discovery will also be undertaken.